Journal of Gastroenterology

Papers
(The TQCC of Journal of Gastroenterology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020200
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020156
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020109
Evidence-based clinical practice guidelines for peptic ulcer disease 202085
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 202172
Evidence-based clinical practice guidelines for irritable bowel syndrome 202070
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments67
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis61
Reducing adenoma miss rate of colonoscopy assisted by artificial intelligence: a multicenter randomized controlled trial57
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retros45
Trajectories of glycaemia following acute pancreatitis: a prospective longitudinal cohort study with 24 months follow-up45
Evidence-based clinical practice guidelines for management of colorectal polyps45
Evidence-based clinical practice guidelines for functional dyspepsia 202144
Efficacy of endoscopic ultrasound with artificial intelligence for the diagnosis of gastrointestinal stromal tumors43
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 201942
Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan41
An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia41
Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study41
Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants39
COVID-19-associated liver injury: from bedside to bench37
Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 202034
Real-time assessment of video images for esophageal squamous cell carcinoma invasion depth using artificial intelligence33
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study33
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study32
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan30
Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy30
Lactobacillus stress protein GroEL prevents colonic inflammation29
Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases28
Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection27
Circular RNA TMEM87A promotes cell proliferation and metastasis of gastric cancer by elevating ULK1 via sponging miR-142-5p26
The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis26
Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)26
Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study26
Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type26
Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan25
Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease24
Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance24
Risk of metastatic recurrence after endoscopic resection for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study24
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis23
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria23
Post-reflux swallow-induced peristaltic wave (PSPW): physiology, triggering factors and role in reflux clearance in healthy subjects23
Constant-severe pain in chronic pancreatitis is associated with genetic loci for major depression in the NAPS2 cohort23
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation23
Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancer22
The gut mycobiome: a novel player in chronic liver diseases21
STING and liver disease21
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis20
Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study)20
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease20
Gastric cancer and genomics: review of literature19
HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation19
Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review19
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts19
Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients19
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study19
Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity19
Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: a systematic review and meta-analysis18
Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database18
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime18
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation18
Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-1918
CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance17
Evidence-based clinical practice guidelines for chronic pancreatitis 202117
Symptom-based diagnostic approach for eosinophilic esophagitis16
Clinical practice guidelines for duodenal cancer 202116
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection16
Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants16
Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs16
Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility16
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer15
Renal manifestations in inflammatory bowel disease: a systematic review15
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials15
Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial15
A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding15
Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma15
The microbiome can predict mucosal healing in small intestine in patients with Crohn’s disease15
Systemic treatment options for advanced biliary tract carcinoma14
Interleukin-35 promotes the differentiation of regulatory T cells and suppresses Th2 response in IgG4-related type 1 autoimmune pancreatitis14
Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment13
Targeting autophagy as a therapeutic strategy against pancreatic cancer13
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program13
Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial13
Wilson disease: revision of diagnostic criteria in a clinical series with great genetic homogeneity13
A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors13
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a12
Traditional serrated adenoma has two distinct genetic pathways for molecular tumorigenesis with potential neoplastic progression12
Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system12
Clinicopathological features and risk factors for lymph node metastasis in early-stage non-ampullary duodenal adenocarcinoma12
The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis12
Achalasia and esophageal cancer: a large database analysis in Japan12
Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease11
The clinical outcome from early versus delayed minimally invasive intervention for infected pancreatic necrosis: a systematic review and meta-analysis11
Oral administration of d-serine prevents the onset and progression of colitis in mice11
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis11
Features of the gut prokaryotic virome of Japanese patients with Crohn’s disease10
Supportive treatment during the periprocedural period of endoscopic treatment for pancreatic fluid collections: a critical review of current knowledge and future perspectives10
Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis10
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis10
Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?10
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis10
Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma10
Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas10
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease10
0.027407169342041